TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 187 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $550,000 | -87.9% | 31,361 | -93.3% | 0.00% | -89.5% |
| Q2 2021 | $4,561,000 | -51.1% | 470,259 | -45.9% | 0.02% | -51.3% |
| Q1 2021 | $9,336,000 | -61.9% | 869,541 | -47.7% | 0.04% | -65.2% |
| Q4 2020 | $24,479,000 | -22.0% | 1,664,171 | -24.7% | 0.11% | -44.3% |
| Q3 2020 | $31,395,000 | +53.2% | 2,209,343 | -12.8% | 0.20% | +48.9% |
| Q2 2020 | $20,498,000 | +96.1% | 2,533,789 | -2.1% | 0.14% | +70.9% |
| Q1 2020 | $10,455,000 | – | 2,587,961 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
| Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
| NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
| Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
| Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
| Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
| Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
| Artal Group S.A. | 150,000 | $870,000 | 0.02% |
| Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |